Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1993 Sep;110(1):392–398. doi: 10.1111/j.1476-5381.1993.tb13822.x

Endothelin-induced contraction and mediator release in human bronchus.

D W Hay 1, W C Hubbard 1, B J Undem 1
PMCID: PMC2176013  PMID: 7693285

Abstract

1. To elucidate the role of acetylcholine and various autacoids in endothelin-1 (ET-1)-induced contraction in human bronchus, the effects of various receptor antagonists were examined. In addition, the ability of ET-1 to stimulate the release of histamine, peptidoleukotrienes and prostanoids was determined. 2. ET-1 was a potent and effective contractile agonist in human bronchus, possessing similar potency and efficacy to leukotriene D4 (LTD4); EC50 (-log M): ET-1 = 7.76 +/- 0.09, n = 7; LTD4 = 8.46 +/- 0.53, n = 7; P > 0.2; maximum response (% 10 microM pre-carbachol): ET-1 = 103.8 +/- 17.4, n = 7; LTD4 = 95.5 +/- 9.3, n = 7; P > 0.6. 3. The cyclo-oxygenase inhibitor, sodium meclofenamate (1 microM) or the potent and selective thromboxane receptor antagonist, SQ 29,548 (1 microM) were without significant effect on ET-1 concentration-response curves. 4. In the presence of sodium meclofenamate (1 microM), the muscarinic receptor antagonist, atropine (1 microM), the platelet activating factor (PAF) receptor antagonist, WEB 2086 (1 microM) or the combination of the H1-histamine receptor antagonist, mepyramine (10 microM) and the leukotriene receptor antagonist, SK&F 104353 (10 microM), were without marked effect on ET-1 concentration-response curves. In addition, the combination of all four receptor antagonists did not antagonize ET-1-induced contraction. 5. ET-1 (0.3 microM) did not stimulate the release of histamine or immunoreactive leukotrienes from human bronchus.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
392

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Advenier C., Sarria B., Naline E., Puybasset L., Lagente V. Contractile activity of three endothelins (ET-1, ET-2 and ET-3) on the human isolated bronchus. Br J Pharmacol. 1990 May;100(1):168–172. doi: 10.1111/j.1476-5381.1990.tb12071.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Balter M. S., Eschenbacher W. L., Peters-Golden M. Arachidonic acid metabolism in cultured alveolar macrophages from normal, atopic, and asthmatic subjects. Am Rev Respir Dis. 1988 Nov;138(5):1134–1142. doi: 10.1164/ajrccm/138.5.1134. [DOI] [PubMed] [Google Scholar]
  3. Battistini B., Sirois P., Braquet P., Filep J. G. Endothelin-induced constriction of guinea pig airways: role of platelet-activating factor. Eur J Pharmacol. 1990 Sep 21;186(2-3):307–310. doi: 10.1016/0014-2999(90)90449-g. [DOI] [PubMed] [Google Scholar]
  4. Brink C., Gillard V., Roubert P., Mencia-Huerta J. M., Chabrier P. E., Braquet P., Verley J. Effects and specific binding sites of endothelin in human lung preparations. Pulm Pharmacol. 1991;4(1):54–59. doi: 10.1016/0952-0600(91)90040-a. [DOI] [PubMed] [Google Scholar]
  5. Casals-Stenzel J. Effects of WEB 2086, a novel antagonist of platelet activating factor, in active and passive anaphylaxis. Immunopharmacology. 1987 Apr;13(2):117–124. doi: 10.1016/0162-3109(87)90048-8. [DOI] [PubMed] [Google Scholar]
  6. Casals-Stenzel J. Protective effect of WEB 2086, a novel antagonist of platelet activating factor, in endotoxin shock. Eur J Pharmacol. 1987 Mar 17;135(2):117–122. doi: 10.1016/0014-2999(87)90602-9. [DOI] [PubMed] [Google Scholar]
  7. Cernacek P., Stewart D. J. Immunoreactive endothelin in human plasma: marked elevations in patients in cardiogenic shock. Biochem Biophys Res Commun. 1989 Jun 15;161(2):562–567. doi: 10.1016/0006-291x(89)92636-3. [DOI] [PubMed] [Google Scholar]
  8. Filep J. G., Battistini B., Côté Y. P., Beaudoin A. R., Sirois P. Endothelin-1 induces prostacyclin release from bovine aortic endothelial cells. Biochem Biophys Res Commun. 1991 May 31;177(1):171–176. doi: 10.1016/0006-291x(91)91964-e. [DOI] [PubMed] [Google Scholar]
  9. Filep J. G., Battistini B., Sirois P. Endothelin induces thromboxane release and contraction of isolated guinea-pig airways. Life Sci. 1990;47(20):1845–1850. doi: 10.1016/0024-3205(90)90287-2. [DOI] [PubMed] [Google Scholar]
  10. Grunstein M. M., Rosenberg S. M., Schramm C. M., Pawlowski N. A. Mechanisms of action of endothelin 1 in maturing rabbit airway smooth muscle. Am J Physiol. 1991 Jun;260(6 Pt 1):L434–L443. doi: 10.1152/ajplung.1991.260.6.L434. [DOI] [PubMed] [Google Scholar]
  11. Hay D. W. Guinea-pig tracheal epithelium and endothelin. Eur J Pharmacol. 1989 Nov 21;171(2-3):241–245. doi: 10.1016/0014-2999(89)90114-3. [DOI] [PubMed] [Google Scholar]
  12. Hay D. W., Henry P. J., Goldie R. G. Endothelin and the respiratory system. Trends Pharmacol Sci. 1993 Jan;14(1):29–32. doi: 10.1016/0165-6147(93)90111-v. [DOI] [PubMed] [Google Scholar]
  13. Hay D. W. Mechanism of endothelin-induced contraction in guinea-pig trachea: comparison with rat aorta. Br J Pharmacol. 1990 Jun;100(2):383–392. doi: 10.1111/j.1476-5381.1990.tb15814.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hay D. W., Muccitelli R. M., Tucker S. S., Vickery-Clark L. M., Wilson K. A., Gleason J. G., Hall R. F., Wasserman M. A., Torphy T. J. Pharmacologic profile of SK&F 104353: a novel, potent and selective peptidoleukotriene receptor antagonist in guinea pig and human airways. J Pharmacol Exp Ther. 1987 Nov;243(2):474–481. [PubMed] [Google Scholar]
  15. Hemsén A., Franco-Cereceda A., Matran R., Rudehill A., Lundberg J. M. Occurrence, specific binding sites and functional effects of endothelin in human cardiopulmonary tissue. Eur J Pharmacol. 1990 Dec 4;191(3):319–328. doi: 10.1016/0014-2999(90)94164-s. [DOI] [PubMed] [Google Scholar]
  16. Henry P. J., Rigby P. J., Self G. J., Preuss J. M., Goldie R. G. Relationship between endothelin-1 binding site densities and constrictor activities in human and animal airway smooth muscle. Br J Pharmacol. 1990 Aug;100(4):786–792. doi: 10.1111/j.1476-5381.1990.tb14093.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Hubbard W. C., Litterst C. L., Liu M. C., Bleecker E. R., Eggleston J. C., McLemore T. L., Boyd M. R. Profiling of prostaglandin biosynthesis in biopsy fragments of human lung carcinomas and normal human lung by capillary gas chromatography-negative ion chemical ionization mass spectrometry. Prostaglandins. 1986 Dec;32(6):889–906. doi: 10.1016/0090-6980(86)90097-3. [DOI] [PubMed] [Google Scholar]
  18. Inoue A., Yanagisawa M., Kimura S., Kasuya Y., Miyauchi T., Goto K., Masaki T. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci U S A. 1989 Apr;86(8):2863–2867. doi: 10.1073/pnas.86.8.2863. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Johnson P. R., Armour C. L., Black J. L. The action of platelet activating factor and its antagonism by WEB 2086 on human isolated airways. Eur Respir J. 1990 Jan;3(1):55–60. [PubMed] [Google Scholar]
  20. Kloog Y., Ambar I., Sokolovsky M., Kochva E., Wollberg Z., Bdolah A. Sarafotoxin, a novel vasoconstrictor peptide: phosphoinositide hydrolysis in rat heart and brain. Science. 1988 Oct 14;242(4876):268–270. doi: 10.1126/science.2845579. [DOI] [PubMed] [Google Scholar]
  21. Lee H. K., Leikauf G. D., Sperelakis N. Electromechanical effects of endothelin on ferret bronchial and tracheal smooth muscle. J Appl Physiol (1985) 1990 Jan;68(1):417–420. doi: 10.1152/jappl.1990.68.1.417. [DOI] [PubMed] [Google Scholar]
  22. Lewis R. A., Holgate S. T., Roberts L. J., 2nd, Oates J. A., Austen K. F. Preferential generation of prostaglandin D2 by rat and human mast cells. Kroc Found Ser. 1981;14:239–254. [PubMed] [Google Scholar]
  23. Maggi C. A., Patacchini R., Giuliani S., Meli A. Potent contractile effect of endothelin in isolated guinea-pig airways. Eur J Pharmacol. 1989 Jan 24;160(1):179–182. doi: 10.1016/0014-2999(89)90670-5. [DOI] [PubMed] [Google Scholar]
  24. Mattoli S., Mezzetti M., Riva G., Allegra L., Fasoli A. Specific binding of endothelin on human bronchial smooth muscle cells in culture and secretion of endothelin-like material from bronchial epithelial cells. Am J Respir Cell Mol Biol. 1990 Aug;3(2):145–151. doi: 10.1165/ajrcmb/3.2.145. [DOI] [PubMed] [Google Scholar]
  25. Mattoli S., Soloperto M., Marini M., Fasoli A. Levels of endothelin in the bronchoalveolar lavage fluid of patients with symptomatic asthma and reversible airflow obstruction. J Allergy Clin Immunol. 1991 Sep;88(3 Pt 1):376–384. doi: 10.1016/0091-6749(91)90100-3. [DOI] [PubMed] [Google Scholar]
  26. Mattoli S., Soloperto M., Mezzetti M., Fasoli A. Mechanisms of calcium mobilization and phosphoinositide hydrolysis in human bronchial smooth muscle cells by endothelin 1. Am J Respir Cell Mol Biol. 1991 Nov;5(5):424–430. doi: 10.1165/ajrcmb/5.5.424. [DOI] [PubMed] [Google Scholar]
  27. McKay K. O., Black J. L., Armour C. L. The mechanism of action of endothelin in human lung. Br J Pharmacol. 1991 Feb;102(2):422–428. doi: 10.1111/j.1476-5381.1991.tb12189.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Ninomiya H., Yu X. Y., Hasegawa S., Spannhake E. W. Endothelin-1 induces stimulation of prostaglandin synthesis in cells obtained from canine airways by bronchoalveolar lavage. Prostaglandins. 1992 May;43(5):401–411. doi: 10.1016/0090-6980(92)90124-c. [DOI] [PubMed] [Google Scholar]
  29. Ogletree M. L., Harris D. N., Greenberg R., Haslanger M. F., Nakane M. Pharmacological actions of SQ 29,548, a novel selective thromboxane antagonist. J Pharmacol Exp Ther. 1985 Aug;234(2):435–441. [PubMed] [Google Scholar]
  30. Payne A. N., Whittle B. J. Potent cyclo-oxygenase-mediated bronchoconstrictor effects of endothelin in the guinea-pig in vivo. Eur J Pharmacol. 1988 Dec 13;158(3):303–304. doi: 10.1016/0014-2999(88)90085-4. [DOI] [PubMed] [Google Scholar]
  31. Power R. F., Wharton J., Zhao Y., Bloom S. R., Polak J. M. Autoradiographic localization of endothelin-1 binding sites in the cardiovascular and respiratory systems. J Cardiovasc Pharmacol. 1989;13 (Suppl 5):S50–S74. doi: 10.1097/00005344-198900135-00013. [DOI] [PubMed] [Google Scholar]
  32. Sarriá B., Naline E., Morcillo E., Cortijo J., Esplugues J., Advenier C. Calcium dependence of the contraction produced by endothelin (ET-1) in isolated guinea-pig trachea. Eur J Pharmacol. 1990 Oct 23;187(3):445–453. doi: 10.1016/0014-2999(90)90371-c. [DOI] [PubMed] [Google Scholar]
  33. Similarity of endothelin to snake venom toxin. Nature. 1988 Sep 22;335(6188):303–303. doi: 10.1038/335303a0. [DOI] [PubMed] [Google Scholar]
  34. Siraganian R. P. An automated continuous-flow system for the extraction and fluorometric analysis of histamine. Anal Biochem. 1974 Feb;57(2):383–394. doi: 10.1016/0003-2697(74)90093-1. [DOI] [PubMed] [Google Scholar]
  35. Springall D. R., Howarth P. H., Counihan H., Djukanovic R., Holgate S. T., Polak J. M. Endothelin immunoreactivity of airway epithelium in asthmatic patients. Lancet. 1991 Mar 23;337(8743):697–701. doi: 10.1016/0140-6736(91)90279-x. [DOI] [PubMed] [Google Scholar]
  36. Turner N. C., Power R. F., Polak J. M., Bloom S. R., Dollery C. T. Endothelin-induced contractions of tracheal smooth muscle and identification of specific endothelin binding sites in the trachea of the rat. Br J Pharmacol. 1989 Oct;98(2):361–366. doi: 10.1111/j.1476-5381.1989.tb12605.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Uchida Y., Ninomiya H., Sakamoto T., Lee J. Y., Endo T., Nomura A., Hasegawa S., Hirata F. ET-1 released histamine from guinea pig pulmonary but not peritoneal mast cells. Biochem Biophys Res Commun. 1992 Dec 15;189(2):1196–1201. doi: 10.1016/0006-291x(92)92331-q. [DOI] [PubMed] [Google Scholar]
  38. Uchida Y., Ninomiya H., Saotome M., Nomura A., Ohtsuka M., Yanagisawa M., Goto K., Masaki T., Hasegawa S. Endothelin, a novel vasoconstrictor peptide, as potent bronchoconstrictor. Eur J Pharmacol. 1988 Sep 13;154(2):227–228. doi: 10.1016/0014-2999(88)90106-9. [DOI] [PubMed] [Google Scholar]
  39. Undem B. J., Pickett W. C., Adams G. K., 3rd Antigen-induced sulfidopeptide leukotriene release from the guinea pig superfused trachea. Eur J Pharmacol. 1987 Oct 6;142(1):31–37. doi: 10.1016/0014-2999(87)90650-9. [DOI] [PubMed] [Google Scholar]
  40. VAN ROSSUM J. M. Cumulative dose-response curves. II. Technique for the making of dose-response curves in isolated organs and the evaluation of drug parameters. Arch Int Pharmacodyn Ther. 1963;143:299–330. [PubMed] [Google Scholar]
  41. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988 Mar 31;332(6163):411–415. doi: 10.1038/332411a0. [DOI] [PubMed] [Google Scholar]
  42. Yanagisawa M., Masaki T. Endothelin, a novel endothelium-derived peptide. Pharmacological activities, regulation and possible roles in cardiovascular control. Biochem Pharmacol. 1989 Jun 15;38(12):1877–1883. doi: 10.1016/0006-2952(89)90484-x. [DOI] [PubMed] [Google Scholar]
  43. Yanagisawa M., Masaki T. Molecular biology and biochemistry of the endothelins. Trends Pharmacol Sci. 1989 Sep;10(9):374–378. doi: 10.1016/0165-6147(89)90011-4. [DOI] [PubMed] [Google Scholar]
  44. Yoss E. B., Spannhake E. W., Flynn J. T., Fish J. E., Peters S. P. Arachidonic acid metabolism in normal human alveolar macrophages: stimulus specificity for mediator release and phospholipid metabolism, and pharmacologic modulation in vitro and in vivo. Am J Respir Cell Mol Biol. 1990 Jan;2(1):69–80. doi: 10.1165/ajrcmb/2.1.69. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES